Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc.verified

INTS

Price:

$0.4603

Market Cap:

$21.70M

Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. The company's lead product candidate is INT230-6, which is in Phase 2 clinical trial for the treatment of refractory solid tumors; and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. It has a collaboration agreement with Merck Sharpe & Dohme Corp. to evaluate the combination of INT230-6 and Keytruda in patients with advanced pancreatic, colon, squamous cell, and bile duct malignancies; Bristol-Myers Squibb Company to evaluate the combination of INT230-6 with Yervoy in patients with ...[Read more]

Industry

Biotechnology

IPO Date

2023-06-30

Stock Exchange

NASDAQ

Ticker

INTS

The PE Ratio as of December 2025 (TTM) for Intensity Therapeutics, Inc. (INTS) is -0.84

According to Intensity Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.84. This represents a change of -42.12% compared to the average of -1.45 of the last 4 quarters.

Intensity Therapeutics, Inc. (INTS) Historical PE Ratio (quarterly & annually)

How has INTS PE Ratio performed in the past?

The mean historical PE Ratio of Intensity Therapeutics, Inc. over the last ten years is -9.49. The current -0.84 PE Ratio has changed 785.48% with respect to the historical average. Over the past ten years (40 quarters), INTS's PE Ratio was at its highest in in the June 2025 quarter at -0.57. The PE Ratio was at its lowest in in the December 2020 quarter at -16.40.

Quarterly (TTM)
Annual

Average

-9.49

Median

-10.18

Minimum

-14.93

Maximum

-1.50

Intensity Therapeutics, Inc. (INTS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Intensity Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 5.93%

Maximum Annual PE Ratio = -1.50

Minimum Annual Increase = -78.53%

Minimum Annual PE Ratio = -14.93

Quarterly (TTM)
Annual
YearPE RatioChange
2024-1.50-78.53%
2023-7.01-33.12%
2022-10.485.93%
2021-9.89-24.53%
2020-13.11-12.21%

Intensity Therapeutics, Inc. (INTS) Average PE Ratio

How has INTS PE Ratio performed in the past?

The current PE Ratio of Intensity Therapeutics, Inc. (INTS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.33

5-year avg

-8.40

10-year avg

-9.49

Intensity Therapeutics, Inc. (INTS) PE Ratio vs. Peers

How is INTS’s PE Ratio compared to its peers?

Intensity Therapeutics, Inc.’s PE Ratio is less than Iterum Therapeutics plc (-0.75), less than Rallybio Corporation (-0.72), greater than iBio, Inc. (-3.37), greater than Pluri Inc. (-0.87), less than Boundless Bio, Inc. (-0.38), less than Sonnet BioTherapeutics Holdings, Inc. (-0.37), greater than Plus Therapeutics, Inc. (-3.42), less than NextCure, Inc. (-0.50), greater than AN2 Therapeutics, Inc. (-0.86), greater than Q32 Bio Inc. (-1.05),

Build a custom stock screener for Intensity Therapeutics, Inc. (INTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intensity Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intensity Therapeutics, Inc. (INTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intensity Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Intensity Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Intensity Therapeutics, Inc. (INTS)?

What is the highest PE Ratio for Intensity Therapeutics, Inc. (INTS)?

What is the 3-year average PE Ratio for Intensity Therapeutics, Inc. (INTS)?

What is the 5-year average PE Ratio for Intensity Therapeutics, Inc. (INTS)?

How does the current PE Ratio for Intensity Therapeutics, Inc. (INTS) compare to its historical average?